MARKET WIRE NEWS
  1. Home
  2. Stock
  3. RX:CC
  4. News
RX:CC
Quote
Short
News
Articles
Message Board

BioSyent Inc. (TSXVC : RX:CC ) News

BioSyent Inc. (TSXVC: RX:CC) News Releases

RX:CC News Releases
RX:CC : TSXVC
GlobeNewswire
BioSyent Announces Health Canada Approval of Thyconvi(TM) (levothyroxine oral solution)
RX:CC : TSXVC
SeekingAlpha
BioSyent declares CAD 0.055 dividend
RX:CC : TSXVC
SeekingAlpha
BioSyent GAAP EPS of C$0.20
RX:CC : TSXVC
GlobeNewswire
BioSyent Declares Second Quarter 2026 Dividend
RX:CC : TSXVC
GlobeNewswire
BioSyent Releases Financial Results for First Quarter 2026
RX:CC : TSXVC
GlobeNewswire
BioSyent Schedules First Quarter 2026 Earnings Release for May 14, 2026
RX:CC : TSXVC
Investing News Network
5 Best-performing Canadian Pharma Stocks in 2026
RX:CC : TSXVC
GlobeNewswire
BioSyent to Present at 2026 Bloom Burton & Co. Healthcare Investor Conference
RX:CC : TSXVC
GlobeNewswire
FeraMAX is Canada's Top-Ranked Iron Supplement for 11 Consecutive Years
RX:CC : TSXVC
Zolmax
Kevin Wilson Sells 1,912 Shares of BioSyent (CVE:RX) Stock
Next 10

Subscribe to Our Newsletter

Get Instant Newsletter Alerts to your Mobile Device and Email as soon as the News or Alerts hit the wire.

Download The Market Wire News App

Get instant news alerts to your mobile device as soon as the news hits the wire. Simply add a stock symbol to your portfolio and our service will alert you anytime there is news.

Market Wire News iPhone App Market Wire News Android App

Link Market Wire News to Your X Account

Link your X account with Market Wire News to automatically tweet trending stocks news and your portfolio stocks news.